paracoccidioidomycosis
Jump to navigation
Jump to search
Epidemiology
- northeastern South America, Central America[3]
Clinical manifestations
- asymptomatic primary pulmonary infection, acute disseminated infection <10%[3]
Management
- itraconazole 100 mg PO QD
- amphotericin B 0.4-0.5 mg/kg/day IV